Although 2020 will probably go down in history as one of the most challenging years experienced during our lifetime, it will also likely be chronicled as one of the best years for the recognition and appreciation of science. As we entered 2020, the COVID-19 pandemic was in its infancy. However, it rapidly evolved through the exponential rise in infections and mortality globally. Much has been achieved during the past 12 months in the fight against COVID-19, but, as we enter 2021, there are considerable concerns about the emergence of a mutant version of the virus and the second wave that we are now facing.

12 Jan 2021
THE MONTHLY January 2021
Arbuthnot Banking Group PLC (ARBB:LON), 925 | City of London Investment Group PLC (CLIG:LON), 361 | ICG Enterprise Trust PLC GBP (ICGT:LON), 1,496 | Oakley Capital Investments Ltd Registered (OCI:LON), 539 | Palace Capital plc (PCA:LON), 222 | Primary Health Properties PLC (PHP:LON), 95.0 | Real Estate Credit Investments Limited (RECI:LON), 128 | Shield Therapeutics Plc (STX:LON), 4.8 | Surface Transforms PLC (SCE:LON), 1.3 | Tissue Regenix Group plc (TRX:LON), 38.0 | Volta Finance Limited (VTA:LON), 685 | Pantheon International Plc (PIN:LON), 336 | Urban Logistics REIT plc (PCILF:OTC), 0

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
THE MONTHLY January 2021
Arbuthnot Banking Group PLC (ARBB:LON), 925 | City of London Investment Group PLC (CLIG:LON), 361 | ICG Enterprise Trust PLC GBP (ICGT:LON), 1,496 | Oakley Capital Investments Ltd Registered (OCI:LON), 539 | Palace Capital plc (PCA:LON), 222 | Primary Health Properties PLC (PHP:LON), 95.0 | Real Estate Credit Investments Limited (RECI:LON), 128 | Shield Therapeutics Plc (STX:LON), 4.8 | Surface Transforms PLC (SCE:LON), 1.3 | Tissue Regenix Group plc (TRX:LON), 38.0 | Volta Finance Limited (VTA:LON), 685 | Pantheon International Plc (PIN:LON), 336 | Urban Logistics REIT plc (PCILF:OTC), 0
- Published:
12 Jan 2021 -
Author:
Martin Hall -
Pages:
33 -
Although 2020 will probably go down in history as one of the most challenging years experienced during our lifetime, it will also likely be chronicled as one of the best years for the recognition and appreciation of science. As we entered 2020, the COVID-19 pandemic was in its infancy. However, it rapidly evolved through the exponential rise in infections and mortality globally. Much has been achieved during the past 12 months in the fight against COVID-19, but, as we enter 2021, there are considerable concerns about the emergence of a mutant version of the virus and the second wave that we are now facing.